SMN1 and spinal muscular atrophy: This is different from the gene dysregulation we previously noted in spinal muscular atrophy (SMA), in which resilient CN3/4 MNs elicited a large early gene response compared with vulnerable spinal and facial (CN7) MNs, which only responded to the loss of the Smn1 gene (survival MN 1) later in disease.